HKSE:06606 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:06606 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the six months ended in Jun. 2023, New Horizon Health received HK$733 Mil more from issuing new shares than it paid to buy back shares. It received HK$219 Mil from issuing more debt. It paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received HK$0 Mil from paying cash dividends to shareholders. It spent HK$8 Mil on other financial activities. In all, New Horizon Health earned HK$944 Mil on financial activities for the six months ended in Jun. 2023.
The historical data trend for New Horizon Health's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New Horizon Health Annual Data | |||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | ||||||
Cash Flow from Financing | -7.05 | 418.19 | 512.62 | 2,184.23 | 84.29 |
New Horizon Health Semi-Annual Data | |||||||||
Dec18 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | |
Cash Flow from Financing | Get a 7-Day Free Trial | 2,187.15 | -32.65 | -12.17 | 95.88 | 930.62 |
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
New Horizon Health's Cash from Financing for the fiscal year that ended in Dec. 2022 is calculated as:
Cash Flow from Financing | (A: Dec. 2022 ) | ||||||||||
= | Issuance of Stock | + | Repurchase of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
= | 1.348 | + | 0 | + | 112.232 | + | 0 | + | 0 | + | -4.844 |
= | 109 |
New Horizon Health's Cash from Financing for the quarter that ended in Jun. 2023 is:
Cash Flow from Financing | (Q: Jun. 2023 ) | ||||||||||
= | Issuance of Stock | + | Repurchase of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
= | 733.013 | + | 0 | + | 218.756 | + | 0 | + | 0 | + | -8.248 |
= | 944 |
Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1,027 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New Horizon Health (HKSE:06606) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
New Horizon Health's issuance of stock for the six months ended in Jun. 2023 was HK$733 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
New Horizon Health's repurchase of stock for the six months ended in Jun. 2023 was HK$0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
New Horizon Health's net issuance of debt for the six months ended in Jun. 2023 was HK$219 Mil. New Horizon Health received HK$219 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
New Horizon Health's net issuance of preferred for the six months ended in Jun. 2023 was HK$0 Mil. New Horizon Health paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
New Horizon Health's cash flow for dividends for the six months ended in Jun. 2023 was HK$0 Mil. New Horizon Health received HK$0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
New Horizon Health's other financing for the six months ended in Jun. 2023 was HK$-8 Mil. New Horizon Health spent HK$8 Mil on other financial activities.
Thank you for viewing the detailed overview of New Horizon Health's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Invesco Advisers, Inc. | 2102 Investment manager | |
Chen Yiyou | 2201 Interest of corporation controlled by you | |
Trident Trust Company (hk) Limited | 2301 Trustee | |
Bancasa Holding Limited | 2201 Interest of corporation controlled by you | |
Mst Development Limited | 2101 Beneficial owner | |
Yao Naxin | 2305 Beneficiary of a trust | |
Janus Henderson Group Plc | 2102 Investment manager | |
Jpmorgan Chase & Co. | 2106 Person having a security interest in shares | |
Invesco Developing Markets Fund | 2106 Person having a security interest in shares | |
Zhu Yeqing | 2101 Beneficial owner | |
Qiming Venture Partners V, L.p. | ||
Qiming Gp V, L.p. | ||
Qiming Corporate Gp V, Ltd. | ||
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si | 2201 Interest of corporation controlled by you |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.